# Sirtex Medical and Magle Group sign distribution and collaboration agreement

Sirtex Medical announced a collaboration and exclusive worldwide distribution agreement with Magle Group for EmboCept S DSM 50 μm, a chemoembolization product for liver and lung tumors. Sirtex will exclusively distribute the product and both companies will pursue a joint development plan.

- Type: Contract
- Announced: 2023-09-08
- Status: announced
- Products: EmboCept S DSM 50 μm, chemoembolization product
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sirtex Medical](https://endata.com/companies/29756.md)
- [Magle Group](https://endata.com/companies/72505.md) (partner)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/sirtex-medical-announces-collaboration-agreement-with-magle-group-for-embocept-s-dsm-50-m-301922047.html), 2023-09-08: "We are delighted to team up with Sirtex to unleash the full commercial potential of EmboCept S, our proprietary product for chemoembolization of inoperable liver and lung tumours."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.